USE OF HEMATOPOIETIC GROWTH FACTOR IN THE MANAGEMENT OF HEMATOLOGICAL SIDE EFFECTS ASSOCIATED TO ANTIVIRAL TREATMENT FOR HCV HEPATITIS. (2010). Mediterranean Journal of Hematology and Infectious Diseases, 2(1), e2010003. https://doi.org/10.4084/mjhid.2010.003